Company Overview
- Website
- cornerstonepharma.com
- Employees
- 17
- Industry
- Materials/Manufacturing
- SIC Code
-
512203 - Drugs and drug proprietaries
Financials & Stats
Revenue
$10B
Recent News & Media
Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results
- Nov 6, 2024
- sec.gov
While FDA mulls Zevra's rare disease med, Rafael merges with Cyclo to push their rival candidate
- Aug 22, 2024
- fiercebiotech.com
Pipeline Moves: Novo Nordisk progression prospects drop after candidate terminated
- Jul 22, 2024
- clinicaltrialsarena.com
Devimistat plus chemotherapy vs chemotherapy alone for older relapsed or refractory patients with AML: results of the ARMADA trial
- May 11, 2024
- ashpublications.org
Phase II Trial of nab-Sirolimus in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumors (AMPECT): Long-Term Efficacy and Safety Update
- Mar 1, 2024
- pmc.ncbi.nlm.nih.gov
Cornerstone Pharmaceuticals Strengthens Scientific Advisory Board with the Appointment of Distinguished Scholar Jason Locasale, Ph.D.
- Jul 6, 2022
- globenewswire.com
Company Leadership
Cornerstone Pharmaceuticals Industry Tags
Companies Similar to Cornerstone Pharmaceuticals
Analyze industry trends and opportunities by examining competitors and companies comparable to Cornerstone Pharmaceuticals, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 10M | 16 | Bethlehem, PA | 2005 | |
| 10M | 28 | New York, NY | 2013 | |
| 10M | Pittsburgh, PA | |||
| 10M | 8 | Houston, TX | 2011 | |
| 10M | 3 | Cary, NC | 2009 |